Zika virus diagnosis: challenges and solutions

R. Peters, Mario Stevenson

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Background: Since its sudden appearance and link to microcephaly in 2015, the number of PubMed references for Zika virus (ZIKV) has risen from 181 to 5163, at time of writing, with a vast proportion focused on the consequences of ZIKV infection during pregnancy. This level of attention underlies increased demand for sensitive and specific diagnostic tools able to assess risk to an unborn child, as well as to understand the dynamics and consequences of viral persistence. Aim: Review the expanding knowledge on ZIKV persistence and diagnostic challenges and summarize current advancements in detection. Sources: Peer-reviewed articles based on the search terms ‘Zika’ and ‘ZIKV’ combined with the terms ‘diagnostics’ ‘point-of-care diagnostics’ ‘viral load’ ‘persistence’ ‘detection’ ‘treatment’ ‘nucleic acid amplification testing’ ‘microsphere’ ‘PVRT’ ‘RVNT’ ‘RT-LAMP’ ‘NASBA’ SIBA’ ‘RPA’ 'sHERLOCK’ ‘ELISA’, and ‘TMA’ as well as laboratory experience of the authors. Content: Topics covered include the emergence of the ZIKV epidemic, pathogenesis of ZIKV infection, the nature of ZIKV persistence, complications in serological diagnosis, tried and novel diagnostic laboratory techniques, and a recent accounting of point-of-care testing (POCT) methods. Implications: Surveillance and research in the case of ZIKV has shifted into a more rapid and coordinated worldwide directive than has occurred with most viral epidemics to date. The particular concentration of outbreaks in resource-limited settings increases the need for simple assays capable of reliable, inexpensive, high-throughput ZIKV diagnosis. This review serves to both catalogue current diagnostic options and consider their suitability at point-of-care.

Original languageEnglish (US)
Pages (from-to)142-146
Number of pages5
JournalClinical Microbiology and Infection
Volume25
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Point-of-Care Systems
Self-Sustained Sequence Replication
Microcephaly
Zika Virus
Viral Load
Microspheres
PubMed
Nucleic Acids
Disease Outbreaks
Enzyme-Linked Immunosorbent Assay
Pregnancy
Research
Zika Virus Infection
Therapeutics

Keywords

  • Diagnosis
  • Diagnostics
  • Emerging infectious disease
  • Global health
  • Infectious disease
  • Nucleic acid amplification testing
  • Point-of-care testing
  • Public health
  • Re-emerging
  • Serology
  • Zika virus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Zika virus diagnosis : challenges and solutions. / Peters, R.; Stevenson, Mario.

In: Clinical Microbiology and Infection, Vol. 25, No. 2, 01.02.2019, p. 142-146.

Research output: Contribution to journalReview article

@article{e90589c2252a440bb30b703c66abf1a4,
title = "Zika virus diagnosis: challenges and solutions",
abstract = "Background: Since its sudden appearance and link to microcephaly in 2015, the number of PubMed references for Zika virus (ZIKV) has risen from 181 to 5163, at time of writing, with a vast proportion focused on the consequences of ZIKV infection during pregnancy. This level of attention underlies increased demand for sensitive and specific diagnostic tools able to assess risk to an unborn child, as well as to understand the dynamics and consequences of viral persistence. Aim: Review the expanding knowledge on ZIKV persistence and diagnostic challenges and summarize current advancements in detection. Sources: Peer-reviewed articles based on the search terms ‘Zika’ and ‘ZIKV’ combined with the terms ‘diagnostics’ ‘point-of-care diagnostics’ ‘viral load’ ‘persistence’ ‘detection’ ‘treatment’ ‘nucleic acid amplification testing’ ‘microsphere’ ‘PVRT’ ‘RVNT’ ‘RT-LAMP’ ‘NASBA’ SIBA’ ‘RPA’ 'sHERLOCK’ ‘ELISA’, and ‘TMA’ as well as laboratory experience of the authors. Content: Topics covered include the emergence of the ZIKV epidemic, pathogenesis of ZIKV infection, the nature of ZIKV persistence, complications in serological diagnosis, tried and novel diagnostic laboratory techniques, and a recent accounting of point-of-care testing (POCT) methods. Implications: Surveillance and research in the case of ZIKV has shifted into a more rapid and coordinated worldwide directive than has occurred with most viral epidemics to date. The particular concentration of outbreaks in resource-limited settings increases the need for simple assays capable of reliable, inexpensive, high-throughput ZIKV diagnosis. This review serves to both catalogue current diagnostic options and consider their suitability at point-of-care.",
keywords = "Diagnosis, Diagnostics, Emerging infectious disease, Global health, Infectious disease, Nucleic acid amplification testing, Point-of-care testing, Public health, Re-emerging, Serology, Zika virus",
author = "R. Peters and Mario Stevenson",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.cmi.2018.12.002",
language = "English (US)",
volume = "25",
pages = "142--146",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Zika virus diagnosis

T2 - challenges and solutions

AU - Peters, R.

AU - Stevenson, Mario

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Background: Since its sudden appearance and link to microcephaly in 2015, the number of PubMed references for Zika virus (ZIKV) has risen from 181 to 5163, at time of writing, with a vast proportion focused on the consequences of ZIKV infection during pregnancy. This level of attention underlies increased demand for sensitive and specific diagnostic tools able to assess risk to an unborn child, as well as to understand the dynamics and consequences of viral persistence. Aim: Review the expanding knowledge on ZIKV persistence and diagnostic challenges and summarize current advancements in detection. Sources: Peer-reviewed articles based on the search terms ‘Zika’ and ‘ZIKV’ combined with the terms ‘diagnostics’ ‘point-of-care diagnostics’ ‘viral load’ ‘persistence’ ‘detection’ ‘treatment’ ‘nucleic acid amplification testing’ ‘microsphere’ ‘PVRT’ ‘RVNT’ ‘RT-LAMP’ ‘NASBA’ SIBA’ ‘RPA’ 'sHERLOCK’ ‘ELISA’, and ‘TMA’ as well as laboratory experience of the authors. Content: Topics covered include the emergence of the ZIKV epidemic, pathogenesis of ZIKV infection, the nature of ZIKV persistence, complications in serological diagnosis, tried and novel diagnostic laboratory techniques, and a recent accounting of point-of-care testing (POCT) methods. Implications: Surveillance and research in the case of ZIKV has shifted into a more rapid and coordinated worldwide directive than has occurred with most viral epidemics to date. The particular concentration of outbreaks in resource-limited settings increases the need for simple assays capable of reliable, inexpensive, high-throughput ZIKV diagnosis. This review serves to both catalogue current diagnostic options and consider their suitability at point-of-care.

AB - Background: Since its sudden appearance and link to microcephaly in 2015, the number of PubMed references for Zika virus (ZIKV) has risen from 181 to 5163, at time of writing, with a vast proportion focused on the consequences of ZIKV infection during pregnancy. This level of attention underlies increased demand for sensitive and specific diagnostic tools able to assess risk to an unborn child, as well as to understand the dynamics and consequences of viral persistence. Aim: Review the expanding knowledge on ZIKV persistence and diagnostic challenges and summarize current advancements in detection. Sources: Peer-reviewed articles based on the search terms ‘Zika’ and ‘ZIKV’ combined with the terms ‘diagnostics’ ‘point-of-care diagnostics’ ‘viral load’ ‘persistence’ ‘detection’ ‘treatment’ ‘nucleic acid amplification testing’ ‘microsphere’ ‘PVRT’ ‘RVNT’ ‘RT-LAMP’ ‘NASBA’ SIBA’ ‘RPA’ 'sHERLOCK’ ‘ELISA’, and ‘TMA’ as well as laboratory experience of the authors. Content: Topics covered include the emergence of the ZIKV epidemic, pathogenesis of ZIKV infection, the nature of ZIKV persistence, complications in serological diagnosis, tried and novel diagnostic laboratory techniques, and a recent accounting of point-of-care testing (POCT) methods. Implications: Surveillance and research in the case of ZIKV has shifted into a more rapid and coordinated worldwide directive than has occurred with most viral epidemics to date. The particular concentration of outbreaks in resource-limited settings increases the need for simple assays capable of reliable, inexpensive, high-throughput ZIKV diagnosis. This review serves to both catalogue current diagnostic options and consider their suitability at point-of-care.

KW - Diagnosis

KW - Diagnostics

KW - Emerging infectious disease

KW - Global health

KW - Infectious disease

KW - Nucleic acid amplification testing

KW - Point-of-care testing

KW - Public health

KW - Re-emerging

KW - Serology

KW - Zika virus

UR - http://www.scopus.com/inward/record.url?scp=85059697233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059697233&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2018.12.002

DO - 10.1016/j.cmi.2018.12.002

M3 - Review article

C2 - 30553031

AN - SCOPUS:85059697233

VL - 25

SP - 142

EP - 146

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 2

ER -